MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) ("MMJ") provides an update on its current portfolio metrics as follows: (see link below)

MMJ's portfolio update is published periodically with any material changes.

MMJ's CEO Jason Conroy said that: "The material change from our 31 August investor presentation is a 12% increase in Harvest One's share price.

Accordingly, our unaudited net tangible assets ("NTA") has increased 16% to 32 cents per share. Yesterday's MMJ share price is a 11% discount to this NTA. The catalysts that may reduce or eliminate this discount in the short term include:

- a sustained improvement in Harvest One's share price;

- release of details on Harvest One's national retail strategy in the coming weeks;

- the imminent listing of MediPharm Labs on the TSX Venture Exchange;

- MMJ shareholder approval of the sale of PhytoTech Therapeutics on 28 September;

- legalisation of recreational cannabis in Canada on 17 October; and

- selective divestments from our portfolio to realise returns and provide funds for other investment opportunities."

To view tables, please visit:

About MMJ Group Holdings Ltd

MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit:



Investor and Media Enquiries:
Jason Conroy
Chief Executive Officer
T: +61-2-8098-0819

Link: Portfolio Update

Related Companies

MMJ Group Holdings Ltd

Harvest One Cannabis Inc

Related Industry Topics:
Food & Beverage Medical Equipment Drugs & OTC Ag Biotechnology Consumers General Health & Pharm General